FindTrial
Sign In

Clinical phenotype and methylphenidate therapy of children with autism comorbid attention deficit hyperactivity disorder

Clinical phenotype and methylphenidate therapy of children with autism comorbid attention deficit hyperactivity disorder

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200059527
Enrollment
Unknown
Registered
2022-05-04
Start date
2022-05-31
Completion date
Unknown
Last updated
2023-03-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

neurodevelopmental disorders

Interventions

Simple ADHD group:None
Simple ASD group:None
ASD+ADHD group:None

Sponsors

The First Hospital of Jilin University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
5 Years to 18 Years

Inclusion criteria

Inclusion criteria: Children aged 5-18 with neurodevelopmental disorders.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
Cognitive function;—

Countries

China

Contacts

Public ContactJia Feiyong

The First Hospital of Jilin University

erkekangfujia@163.com+86 13943003914

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026